Wednesday 18 May 2016, Amsterdam
The report, now available on ASDReports, "Empty Capsules Market by Product (Gelatin (Porcine, Bovine, Bone Meal), Non-Gelatin (HPMC, Pullulan)), by Application (Antibiotics, Vitamins, Anti-Inflammatory, Ant anemic) & by End User (Pharmaceutical, Nutraceutical, Cosmetics) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.
The empty capsules market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 7.2% between 2016 and 2021 to reach USD 2.13 Billion by 2021. Growth in this market can primarily be attributed to factors such as the rapidly increasing aging population, increasing applications of empty capsules in the pharmaceutical and nutraceutical industries, growing consumer preference towards capsule-based formulations, and emerging innovative technologies.
The empty capsules market is segmented based on products, therapeutic applications, end users, and regions. On the basis of products, the market is further segmented into gelatin and non-gelatin capsules. The gelatin capsules segment is subsegmented into pig meat gelatin, bovine-derived, bone meal, and others (fish and poultry gelatin). The non-gelatin capsules market is the fastest-growing segment in the global empty capsules market. This segment has also been furThe report "Molluscicides Market by Source (Chemical Molluscicides, Biological Molluscicides), Type (Metaldehyde, Methiocarb, Ferrous Phosphate), Method of Application (Sprays, Powders, Pellets), Application, and by Region - Global Forecast to 2021", The molluscicides market is projected to reach a value of USD 695.8 Million by 2021, at a CAGR of 4.1% from 2015 to 2020. The market is driven by factors such as increasing cultivation of horticulture crops, sudden influx of snails in new regions, and newly developed rain-fast characteristics of molluscicide products.
The powder method of application segment is projected to be the fastest-growing market during the period 2016–2021The powder formulations of molluscicides are gaining popularity among agricultural producers due to the ease of application of this method. Powders can be used in various levels of active ingredient concentrations and also in the form of combinations of two or more active ingredients. This particular method also prevents unwarranted harm to non-target species.
Rapeseed, corn, rice, wheat, lettuce, and strawberry are the major crops in the molluscicides marketField crops accounted for the largest share in application of molluscicides in 2015. Under this category rapeseed, corn, rice, and wheat are the crops that are projected to account for the major shares in 2021. Horticultural crops accounted for the second largest share in 2015. The strawberry crop under this category is expected to grow at the highest CAGR primarily due to the growing demand from various food industries that require higher yields of cultivation.
North America and EU regions dominated the molluscicides market in 2015The North American region was the largest market for molluscicides in 2015. Countries such as U.S., Canada, and Mexico are major producers of corn, rapeseed, and horticultural crops. The countries in the EU such as France, Italy, U.K., Spain, and Germany produce fruit and vegetable crops and possess a large domestic market for turfs & ornamentals. Even though EU molluscicde regulations are stringent, the production of molluscicides is high due to snail and slug infestation that causes significant economic losses. Slug infestation is high on lettuce, tomato, and strawberry fields in the U.S. Countries such as Brazil and Argentina are also active for molluscicides usage. Asia-Pacific countries are at the growth stage in this market. China is the major country, followed by Japan, Australia, and New Zealand.
This report includes a study of marketing and development strategies, along with the product portfolio of leading companies. It includes the profiles of leading companies such Lonza Group AG (Switzerland), Bayer CropScience AG (Germany), BASF SE (Germany), Adama Agricultural Solutions Ltd (Israel), Marrone Bio Innovations Inc. (U.S.), American Vanguard Corporation (U.S.), De Sangosse (France), W. Neudorff GmbH KG (Germany), Doff Portland Ltd (U.K.), and Certis Europe B.V (the Netherlands).
In terms of insights, this research report has focused on various levels of analyses industry analysis, market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging & high-growth segments of the global molluscicides market, high-growth regions, countries, and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.ther segmented into hydroxypropyl methyl cellulose (HPMC) and pullulan and starch material. On the basis of therapeutic applications, the market is further segmented into antibiotic and antibacterial drugs, vitamins and dietary supplements, antacid and antiflatulent preparations, antianemic preparations, anti-inflammatory and anti-rheumatic drugs, cardiac therapy drugs, cough and cold preparations, and other therapeutic applications. Similarly, based on end users, the empty capsules market is subsegmented into the pharmaceutical industry, nutraceutical industry, cosmetics industry, and research laboratories. On the basis of geography, the empty capsules market is segmented into North America, Europe, Asia-Pacific, and the Rest of the world (Latin America and Middle East & Africa).
In 2015, the gelatin capsules segment accounted for the largest share of the global empty capsules product segment. The large share of this segment is mainly due to factors such as the development of a wide range of formulations using hard gelatin capsules, long-term safety of encapsulated drug molecules, desired drug dissolution characteristics, and sustained release properties. However, the non-gelatin capsules segment is expected to grow at the highest CAGR during the forecast period. In 2015, the antibiotic and antibacterial drugs segment had the largest share in the empty capsules therapeutic applications market, primarily due to the rising prevalence of infectious and chronic diseases.
North America held the largest share in the empty capsules market owing to the large existing industrial base and the large number of ongoing research activities. The large share of this region is due to the growing preference for capsule-based nutraceutical formulations. On the other hand, the Asia-Pacific (APAC) region is expected to witness the highest growth rate during the forecast period, due to the flourishing healthcare market and growing pharmaceutical manufacturing in this region.
The market players, namely, ACG Worldwide (India), Capsugel (U.S.), CapsCanada Corporation (Canada), Qualicaps, Inc. (U.S.), and Suheung Co., Ltd. (Korea) held a major share of the empty capsules market. The companies majorly focused on strategies such as expansions, acquisitions, and new product launches to sustain their positions in the market. The other key players in the global empty capsules market include Sunil Healthcare Ltd. (India), Snail Pharma Industry Co. (China), Bright Pharma Caps (U.S.), Roxlor LLC (U.S.), and Medi-Caps Ltd. (India).
